Trials / Completed
CompletedNCT03516643
Extracorporeal Shockwave Myocardial Revascularization in Refractory Angina
Improving Myocardial Perfusion in Refractory Angina. Extracorporeal Shockwave Myocardial Revascularization in a Large Prospective Cohort
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- University of Turin, Italy · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective cohort study to examine the efficacy of ESMR application in patients with refractory angina despite optimal medical therapy, not suitable for further PCI or CABG. Characteristics such as angina class scores (CCS class score), nitroglycerin consumption and hospitalization were compared at baseline and 1, 6 and 12 months after ESMR therapy. The effect on cardiac perfusion was assessed at 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Extracorporeal Shockwave Myocardial Revascularization | extracorporeal shockwave in ischemic area evaluated by SPECT |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-01-01
- Completion
- 2018-04-01
- First posted
- 2018-05-04
- Last updated
- 2018-05-04
Source: ClinicalTrials.gov record NCT03516643. Inclusion in this directory is not an endorsement.